By John Kennedy ( May 4, 2017, 8:28 PM EDT) -- AbbVie Inc.'s shareholders on Thursday hit the biopharmaceutical company's board of directors with a proposed class action in Delaware Chancery Court, claiming the directors hid their decision to back out of a $55 billion merger with Shire PLC, opening the company up to major losses when the truth came out....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.